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One Genome, Many Proteomes
Completion of a human genome sequence will
change biology and medicine in many ways
(1,2). Most fundamentally, the information in
a well-annotated genome sequence represents
a catalog of all possible gene products in
human cells. Thus, analyses of gene expression
provide important information about the
states of cells and about their responses to
chemicals and other environmental stimuli.
Genes ultimately code for proteins, which per-
form most of the functions of cells. The pro-
teome is the protein complement of the
expressed genes in a cell. Whereas the genome
of an organism is essentially invariant in all its
cells, proteomes vary among different cell
types and also vary with time. This is because
not all genes in an organism are expressed in
all its cells and levels of gene expression vary
with time. Moreover, any protein product of a
single gene may exist in multiple forms
because of posttranslational modiﬁcations, the
existence of mutants, and the formation of
splice variants. Indeed, it appears that many
cellular proteins may exist in at least two forms
at any given moment. Thus, the complexity of
the proteome presents challenges not seen in
gene expression analyses.
Analytical Proteomics
Mass spectrometry (MS) is the key technology
presently driving proteomics (3,4). MS analy-
sis of peptides generated by proteolysis of pro-
tein samples provides information sufﬁcient to
identify the proteins. I present an overview of
analytical proteomics methodology in Figure
1. Protein mixtures (cell extracts, subcellular
fractions, protein complexes, etc.) are ﬁrst sub-
jected to some type of separation to resolve the
mixture into several fractions containing fewer
components. The prototypical approach
employs two-dimensional sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (2D
SDS–PAGE), but many other protein separa-
tion methods can be used. The proteins in the
separated fractions then are digested chemi-
cally or enzymatically to produce a mixture of
peptides. The peptides then are analyzed by
MS either with or without some prior chro-
matographic or electrophoretic separation.
The MS data are then evaluated with the aid
of database search algorithms, which correlate
MS data with protein or nucleotide sequences,
thus identifying the proteins represented in
the mixture of peptides.
Table 1 is a summary of the features of the
two principal approaches to MS analysis of
peptide mixtures. Matrix-assisted laser desorp-
tion ionization–time of ﬂight (MALDI–TOF)
MS employs laser energy to generate peptide
ions from co-crystallized mixtures of peptides
and ultraviolet-absorbing organic acids.
MALDI–TOF analyses yield mass measure-
ments of peptides, which can then be searched
against databases with computer-assisted
search algorithms to identify the proteins from
which the peptides were derived. This tech-
nique, termed peptide mass ﬁngerprinting, is a
highly robust, useful means of rapidly identify-
ing proteins, particularly in organisms for
which completed genome sequences or exten-
sive protein sequence databases are available
(4,5). However, this approach becomes
increasingly difﬁcult in higher organisms for
which reliably annotated genome and protein
sequences are unavailable. Moreover, the
increasing predominance of gene paralogs
(highly homologous genes) in higher organ-
isms (6) makes it more difﬁcult to unambigu-
ously identify proteins by this technique (7).
Electrospray ionization–tandem mass
spectrometry (ESI–MS–MS) has emerged as
the second major MS technique to analytical
proteomics (3). In ESI–MS–MS, peptides are
ionized under high voltage at atmospheric
pressure and then analyzed with either ion
trap, triple quadrupole, or quadrupole–time-
of-ﬂight mass analyzers. In these analyses, the
peptide ions are subjected to collision-
induced dissociation, which generates frag-
ment ions that are detected by the tandem
mass analyzer. These fragmentation patterns
are recorded in the resulting MS–MS spectra,
which provide fingerprints that define the
sequence of peptide ions. The development
of the Sequest algorithm and software by
Yates and Eng made possible the identiﬁca-
tion of peptides from correlation of their
MS–MS spectra with virtual MS–MS data
generated from protein and nucleotide
sequence databases (8). Automated liquid
chromatography–tandem mass spectrometry
(LC–MS–MS; “data-dependent”) scanning
acquires MS–MS spectra for hundreds to
thousands of peptides in a single LC analysis.
The combination of data-dependent scanning
and Sequest automates the identification of
proteins from LC–MS–MS analysis of com-
plex peptide mixtures (9). Combination of
MS–MS with reverse-phase or tandem LC
(e.g., ion exchange–reverse phase) makes
LC–MS–MS the most powerful approach to
protein identification and characterization
(10). Moreover, fragmentation of peptides in
MS–MS provides unambiguous conﬁrmation
not only of sequence but also of the location
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Proteomics is the study of proteomes, which are the collections of proteins expressed in cells.
Whereas genomes are essentially invariant in different cells in an organism, proteomes vary from
cell to cell, with time and as a function of environmental stimuli and stress. The integration of
new mass spectrometry (MS) methods, data analysis algorithms, and information from databases
of protein and gene sequences has enabled the characterization of proteomes. Many environmen-
tal agents directly or indirectly generate reactive electrophiles that covalently modify proteins.
Although considerable evidence supports a key role for protein adducts in adverse effects of chem-
icals, limitations in analytical technology have slowed progress in this area. New applications of
liquid chromatography–tandem mass spectrometry (LC–MS–MS) now offer the potential to
identify protein targets of reactive electrophiles and to map adducts at the level of amino acid
sequence. Use of the data-analysis tools Sequest and SALSA (Scoring Algorithm for Spectral
Analysis) together with LC–MS–MS analyses of protein digests enables the identiﬁcation of mod-
iﬁed forms of proteins in a sample. These approaches can map adducts to speciﬁc amino acids in
protein targets and are being adapted to searches for protein adducts in complex proteomes.
These tools will facilitate the identiﬁcation of new biomarkers of chemical exposure and studies of
mechanisms by which protein modifications contribute to the adverse effects of environmental
exposures. Key words: functional genomics, mass spectrometry, protein adducts, proteomics,
stress responses. Environ Health Perspect 110(suppl 1):3–9 (2002).
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Protein Modiﬁcation in
Chemical Toxicity and
Carcinogenesis
In the 1940s, the Millers ﬁrst discovered that
chemical carcinogens underwent biotransfor-
mation to metabolites that covalently bound
tissue macromolecules (11). The subsequent
discoveries that binding to DNA led to mol-
ecular lesions, mutations, and cancer estab-
lished a paradigm that has dominated the
study of chemical carcinogenesis ever since.
Nevertheless, the bulk of reactive intermedi-
ates formed in cells bind to cellular proteins.
The significance of protein binding went
largely unappreciated until the work of
Brodie, Gillette, Jollow, Mitchell, and col-
leagues in the early 1970s established that
protein covalent binding of acetaminophen
and bromobenzene was closely associated
with toxicity and suggested a causative role
for protein adduction in cell injury (12–15).
In the years since, a large body of data has
emerged to support this view, yet the rela-
tionship between protein covalent binding
and toxicity certainly is far from simple. In
some cases, nontoxic analogs of toxic chemi-
cals also covalently bind to proteins (16–18);
in others, toxicity can be modulated without
affecting covalent binding (19). From these
data has emerged the view that adduction of
some protein targets is critical to injury,
whereas adduction of others is not (20–22).
Several nucleophilic residues in proteins
are potential targets for reactive electrophiles.
In general, the most reactive protein nucle-
ophiles are cysteine thiols, lysine ε-amines,
histidine imidazoles, and protein N-terminal
amines. Somewhat less nucleophilic sites that
nonetheless may be targets for highly reactive
electrophiles include methionine sulfur, tyro-
sine phenols, arginine guanidinium, serine
and threonine hydroxyls, and possibly even
aspartate and glutamate carboxyls (23).
Attempts to identify protein targets of
reactive chemicals have been complicated by
the same difﬁculties that have plagued the ﬁeld
of protein analysis. Protein structures are com-
plex, and proteins vary greatly in their molecu-
lar sizes and physical properties. Specific
detection of adducted species is difficult
because unmodiﬁed proteins are always pre-
sent in excess and because of the multiplicity
of protein targets for most electrophiles. Lance
Pohl and his colleagues ﬁrst pioneered the use
of antibodies in the early 1980s to detect
adducts in hepatic proteins from humans and
animals treated with the volatile anesthetic
halothane (24). Approximately a half-dozen
hepatic proteins adducted by the halothane
metabolite triﬂuoroacetyl chloride have been
detected and subsequently identiﬁed by con-
ventional purification methods and Edman
sequencing (20). The identified targets are
abundantly expressed proteins of the endoplas-
mic reticulum, close to the site of formation of
the extremely reactive acyl halide metabolite.
Other work by the Hinson and Cohen
groups over the past decade has employed
antibody-based approaches to identify hepatic
protein adducts of acetaminophen. These
groups have collectively identiﬁed seven pro-
tein targets adducted by the N-acetyl-p-ben-
zoquinoneimine metabolite of acetaminophen
(20). These include cytosolic, mitochondrial,
and microsomal proteins. Similar antibody-
based detection approaches have been
employed to detect protein adducts of benzo-
quinone (from bromobenzene) (25),
diclofenac (26), S-(1,1,2,2-tetraﬂuoroethyl)-L-
cysteine (27), and dichloroacetyl chloride
(from trichloroethylene) (22). Other recent
work by Myers et al. employed densitometric
analyses of proteins on 2D SDS–PAGE
whose apparent levels were altered by either
in vivo treatment with acetaminophen or its
nonhepatotoxic regioisomer 3-hydroxyac-
etanilide (28). However, it was not possible to
determine the identities of most of the
proteins affected.
Each published protein adduct identifi-
cation has resulted from months or years of
labor-intensive work to prepare antibodies,
identify adducts, purify adducted proteins,
and then characterize the proteins—all mak-
ing this some of the most labor-intensive
work in mechanistic toxicology. In none of
these investigations has the sequence context
of specific adducts been unambiguously
established. These approaches also are lim-
ited by the availability, quality, and speci-
ficity of antibodies to adducts. Indeed, the
ability of the antibodies to uniformly recog-
nize adducts on different proteins and in dif-
ferent sequence contexts is open to question.
Progress in this field has been greatly hin-
dered by the obstacles to identifying speciﬁc
protein targets of chemicals and in mapping
sequence speciﬁcity of adduction.
Application of Mass
Spectrometry to Analysis of
Adducts on Known Proteins
Several studies have applied MS to study the
modiﬁcation of peptides and small proteins
by reactive electrophiles. Early work
employed fast atom bombardment–tandem
mass spectrometry (FAB–MS–MS) to map
the sequence locations of adducts formed by
S-(2-chloroacetyl)glutathione, S-(2-chloro-
ethyl)glutathione, and S-(N-methylcar-
bamoyl)glutathione in short model peptides
in vitro (29–31). Further work from the
Burlingame laboratory and subsequently
from several other groups employed
FAB–MS–MS or ESI–MS–MS to map
xenobiotic modifications on several model
proteins, including bovine serum albumin
(BSA), human serum albumin, human
hemoglobin, human apolipoprotein B-100,
and Escherichia coli thioredoxin (32–38).
These investigators demonstrated the feasi-
bility of using MS analysis to pinpoint cova-
lent modifications of proteins on specific
amino acid residues within a known protein
sequence. Although the ability to map modi-
fications generated in vitro on known pro-
teins represents an important advance,
electrophiles in complex living systems prob-
ably modify many proteins whose identities
are unknown. This requires the extension of
MS-based adduct analyses to proteomes.
Proteomic Analyses 
of Adducts
Proteomics approaches offer the opportunity
to search for adducts in proteomes containing
many proteins in both modiﬁed and unmodi-
fied forms. As noted above, a fundamental
problem in such work is that the identities of
the protein targets are usually unknown. An
innovative approach to this problem was pub-
lished by Qiu et al., who used MALDI–TOF
MS to identify protein targets of the hepato-
toxic analgesic drug acetaminophen (39).
Total hepatic proteins from mice treated with
[14C]acetaminophen were separated by 2D
SDS–PAGE, and spots containing radiolabel
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Figure 1. General scheme for proteomic analysis.
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Table 1. Comparison of MALDI–TOF MS and ESI–MS–MS approaches to protein identiﬁcation.
MALDI–TOF MS ESI–MS–MS
Samples on a slide (crystalline matrix) Samples in solution (high-performance liquid chromatography)
Spectra indicate masses of peptide ions MS–MS spectra reveal fragmentation patterns
Protein identiﬁcation by peptide  Protein identiﬁcation by cross-correlation algorithms or de novo 
mass ﬁngerprinting interpretationwere subjected to in-gel tryptic digestion and
MS analysis (Figure 2). Postsource decay of
peptide adduct molecular ions was used to
determine sequence information for peptides
derived from the proteins. The peptide masses
and sequence information were used, in con-
junction with protein database searching, to
identify 25 protein targets, including the six
that had been identiﬁed previously as targets
by immunochemical methods over the past
decade. This study was the ﬁrst to implement
a true proteomics approach to identify pro-
tein targets of reactive intermediates.
Nevertheless, it is important to point out that
these analyses did not, strictly speaking, iden-
tify adducts. Instead, they identiﬁed proteins
that were present in two-dimensional gel
spots that contained acetaminophen radiola-
bel. Although it is likely that the spots con-
tained a mixture of adducted and unadducted
proteins, adducts were not demonstrated on
the proteins identified by sequencing.
Another problem with this general approach
is that radiolabel is required to select proteins
from the two-dimensional gels for MS analy-
sis. Aside from the expense and frequent syn-
thetic difficulties of using radioisotopes,
limitations in the speciﬁc activity of most use-
ful radiochemicals will tend to bias the
observer toward the detection of adducts to
high-abundance proteins.
The SALSA Algorithm
As noted above, the only MS approach that
unambiguously allows the assignment of
sequence location of modiﬁcations in a pro-
tein is LC–MS–MS. For LC–MS–MS analy-
sis, the proteins in a sample must first be
digested to peptides. Because one does not
know which peptides in a mixture bear the
modiﬁcations, the only logical approach is to
collect MS–MS spectra for all the peptides
in a sample, both modiﬁed and unmodiﬁed,
and then determine which spectra corre-
spond to modiﬁed peptides.
The Sequest algorithm provides a useful
means of identifying proteins represented in
a peptide digest (see above). However, not all
the MS–MS data obtained in LC–MS–MS
analyses can be evaluated successfully with
Sequest. Although Sequest can take into
account some known peptide modiﬁcations
on speciﬁc amino acids when matching spec-
tra to database sequences, large or unexpected
modifications or sequence variations not
found in databases will yield inaccurate pro-
tein identiﬁcations. Thus, a data evaluation
tool suited to detecting adduct-specific fea-
tures in MS–MS spectra is needed to selec-
tively identify spectra of modiﬁed peptides.
We have developed a novel algorithm
and software called SALSA (Scoring
Algorithm for Spectral Analysis) (40). The
SALSA algorithm evaluates MS–MS spectra
for speciﬁc, user-deﬁned features, including
product ions at speciﬁc m/z values, neutral or
charged losses from singly or doubly charged
precursors, and ion pairs or series (Figure 3).
The MS–MS scans containing the speciﬁed
features are then scored on the basis of the
intensities of the detected ion signals. The
scores are independent of the concentrations
of the analytes in the mixture. Peptide
adducts formed with the electrophiles 1,4-
benzoquinone (41), 2-chloroacetyl chloride
and S-(2-chloroacetyl)glutathione(42),
7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetra-
hydrobenzo[a]pyrene (43), and dehy-
dromonocrotaline pyrrole (40) all have been
shown to display characteristic combinations
of product ions, neutral or charged losses, or
ion pairs that would enable detection of their
MS–MS spectra with SALSA. Table 2 is a
summary of characteristic product ions (PI),
neutral losses (NL), charged losses (CL), and
ion pairs (IP) that appear in MS–MS spectra
of peptides bearing endogenous and xenobi-
otic-derived modifications. This list is not
necessarily a complete compilation of such
MS–MS features, yet it illustrates the variety
of fragmentation characteristics that distin-
guish posttranslational modifications and
xenobiotic adducts. SALSA is particularly
applicable to identifying spectra of modiﬁed
peptides that display multiple speciﬁc prod-
uct ions, neutral losses, charged losses and
ion pairs in different combinations (40).
The SALSA algorithm also can search for
MS–MS spectra that display a series of ions
spaced by designated m/z values. These series
can correspond to b- or y-ion series that are
indicative of speciﬁc peptide sequences (44).
This feature is particularly valuable for ﬁnding
MS–MS spectra from specific peptide
sequences and can distinguish highly similar
peptides of the same m/z value that have sub-
tle sequence differences. SALSA is thus suited
to the detection of MS–MS spectra displaying
either speciﬁc posttranslational modiﬁcations
(e.g., phosphorylation) or sequence variations
(e.g., mutants or polymorphic variants).
It is important to emphasize that SALSA
scores are determined by several factors,
including a) the search strategy used, b) the
length of the search motif, c) the number of
ions that match the search series, and d) the
intensities of the scored ions (44). SALSA
scores do not provide an absolute measure of
spectral quality or the fidelity of the match
between the search motif and the MS–MS
spectrum. Thus, the absolute values of SALSA
scores are less important than the relative val-
ues for ranking MS–MS scans in a data set. A
ranking of the MS–MS scans by SALSA score
quickly identiﬁes those MS–MS scans origi-
nating from the target peptide or its modiﬁed
or variant forms. We have not attempted to
statistically analyze the relationship between
SALSA scores, MS–MS spectral characteris-
tics, and peptide sequences. Depending on
the search strategy used and features of indi-
vidual spectra, SALSA may assign relatively
high scores to spectra that do not contain the
Reviews, 2002 • Environmental proteomics
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Figure 2. Proteomic approach employed by Qiu et al. (32) to identify putative protein targets of
[14C]acetaminophen.
Figure 3. MS–MS spectral features detected by
the SALSA algorithm. Asterisk (*) indicates a spe-
ciﬁc production ion. See text for discussion.
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AGD W Kmotif of interest. Thus, it is important that
the user validate SALSA “hits” by inspection
of the indicated spectra.
Mapping Protein Modiﬁcations
with SALSA and Sequest
Recent work in our laboratory indicates that
SALSA can be used to detect modiﬁed forms
of BSA, which we have employed as a model
for these studies (44). These studies analyzed
commercially purchased BSA (Sigma,
St. Louis, MO USA), which was not sub-
jected to any treatment with oxidants or
xenobiotics prior to analysis. Tryptic digests
of BSA were analyzed by LC–MS–MS, and
the data then were analyzed with Sequest and
SALSA. Figure 4 depicts a summary of the
data. Sequest analysis of the data identified
MS–MS spectra corresponding to 37 BSA
tryptic peptides and accounting for 66.2%
coverage by amino acid sequence. A SALSA
analysis of the same data ﬁle was performed
with ion series searches corresponding to the
central sequence of each peptide. The SALSA
analysis assigned signiﬁcant scores to the same
MS–MS spectra assigned to the peptides
by Sequest. In Figure 4, the highlighted
sequences indicate peptides to which MS–MS
spectra were assigned by Sequest and SALSA.
The ﬁrst number in parentheses below each
highlighted peptide corresponds to the num-
ber of MS–MS scans assigned to the sequence
by Sequest; the second number corresponds
to the number of MS–MS spectra assigned to
the sequence by SALSA, and the third num-
ber indicates the number of modiﬁed or vari-
ant forms of that peptide sequence assigned to
MS–MS spectra by SALSA. The data sum-
mary indicates that SALSA detected the
MS–MS spectra for unmodiﬁed peptides also
detected by Sequest. However, SALSA
detected MS–MS spectra of several variant
peptides not assigned by Sequest. All detected
MS–MS scans assigned as variants of a target
sequence displayed very strong y-ion series
identity or homology (i.e., the series was dis-
placed along the m/z axis) with the unmodi-
fied peptides. As indicated in Figure 4, one
MS–MS scan corresponding to a variant pep-
tide was found for eight of the peptides
detected. Two variants were found for
another peptide (KVPQVSTPTLVEVSR),
three variants were found for two other
peptides (LFTFHADICTLPDTEK and
TVMENFVAFVDK), and four variants
each were found for three other peptides
(MPCTEDYLSLILNR, CCTESLVNR, and
CCAADDKEACFAVEGPK). Inspection of
the MS–MS scans corresponding to variant
forms of the peptides MPCTEDYLSLILNR
and CCAADDKEACFAVEGPK indicated
that they were due primarily to M+16 and
M+32 variants, reﬂecting oxidative modiﬁca-
tion at the cysteine and cysteine/methionine,
respectively.
An important advantage of employing
LC–MS–MS and SALSA as described in the
example above is that modiﬁcations to a pro-
tein can be detected without prior knowledge
of the exact chemical nature of the modifying
species. In previous studies of chemical modi-
ﬁcation of proteins (see above), the investiga-
tors knew the chemical nature of the
modifying species and thus could directly
search the MS data for MS–MS spectra of
known peptides modified by chemicals of
known mass. However, unanticipated modiﬁ-
cations would not be detectable by this
approach. Moreover, some modiﬁcations by
known electrophiles may yield adducts that
undergo adventitious oxidation, hydrolysis, or
other modiﬁcations during sample work-up.
Reviews, 2002 • Liebler
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DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAK TCVADESHAGCEK
(1,1,0)           (3,3,0)                                                             (2,2,0)                   (1,2,1)
SLHTLFGDELCK VASLR ETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFK
(1,2,1)             (1,1,0)            (1,1,0)                                                                        (1,1,0)
ADEKKFWGKYLYEIAR RHPYFYAPELLYYANK YNGVFQECCQAEDK GACLLPKIETMREKVLASSAR
(1,1,0)               (1,2,1)                             (2,3,1)                  (1,1,0)
QRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTK LVTDLTK VHKECCHGDLLECADDRADLAK
(2,2,0)        (1,2,1)                 (1,1,0)
YICDNQDTISSK LKECCDKPLLEK SHCIAEVEKDAIPENLPPLTADFAEDKDVCKNYQEAK
(2,2,1)                   (2,2,0)                (1,1,0)
DAFLGSFLYEYSR RHPEYAVSVLLRLAKEYEATLEECCAK DDPHACYSTVFDKLKHLVDEPQNLIK
(3,4,1)                     (3,3,0)                          (1,1,0)                     (1,1,0)                       (3,3,0)
QNCDQFEK LGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCTKPESERMPCTEDYLSLILNR
(1,1,0)             (5,6,1)                               (3,5,2)                                                                   (2,6,4)
LCVLHEK TPVSEKVTKCCTESLVNR RPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIK
(1,1,0)     (1,1,0)              (1,4,4)                   (1,1,0)                                        (3,5,3)
KQTALVELLKHKPKATEEQLKTVMENFVAFVDK CCAADDKEACFAVEGPK LVVSTQTALA
(2,2,0)                                           (3,6,3)                          (1,7,4)                        (1,1,0)
Figure 4. BSA tryptic peptides for which MS–MS scans were detected by Sequest and SALSA. Detected
peptides are indicated by highlighted sequences. Numbers in parentheses in the format (a,b,c) beneath
each highlighted sequence indicate a) the number of MS–MS scans for the indicated sequence detected
by Sequest, b) the number of MS–MS scans for the indicated sequence detected by SALSA, and c) the
number of MS–MS scans for variants of the indicated sequence detected by SALSA. Reproduced from
Mason and Liebler (41) with permission of the American Chemical Society.
Table 2. Representative MS–MS spectral characteristics of endogenous and xenobiotic-derived peptide
modiﬁcations.
Modiﬁcation (amino acid)a Spectral characteristicsb Reference
Phosphorylation (S, T) NL 98; IP 167 (pS), 181 (pT) (62,63)
Phosphorylation (Y) IP 243 (64)
Nitration (Y) IP 208 (65)
Benzoquinone (C) NL 142; IP 142, 211 (41)
Pyrrolizidine dehydropyrrole (M+135 adduct) (C) PI 118, 120, 136; NL 135; CL 135 (40)
Pyrrolizidine dehydropyrrole (M+117 adduct) (C) PI 118, 120; NL 117; CL 117 (40)
N,N-Diethylthiocarbamoyl (C) PI 100, 72; IP 202; CL 100 (66)
Benzo[a]pyrene diol epoxide (H) PI 303, 285, 257; NL 303; CL 303 (43)
Chrysene diol epoxide (U) PI 279, 261,233; NL 279; CL 279 (43)
5-Methylchrysene diol epoxide (U) PI 293, 275, 247; NL 293; CL 293 (43)
Benzo[g]chrysene diol epoxide (U) PI 328, 311, 283; NL 328; CL 328 (43)
S-[2-S-(Cysteinyl)acetyl]glutathione (C) PI 75, 129, 178, 274, 307, 349; NL 75, 129, 
273, 307, 348; IP 450 (42)
S-[2-S-(Cysteinyl)ethyl]glutathione (C) NL 75, 129; IP 436 (31,38)
S-Carboxymethyl (C) IP 161; NL 60 (42)
2-Chloroacetyl (C, K, H) IP 179 (C), 213 (H), 204 (K); NL 36, 78, 96, 114 (42)
4-Hydroxynonenal (H)c IP 295 (37)
Abbreviations: CL, charged loss; IP, ion pair; NL, neutral loss; PI, product ion. 
aStandard one-letter codes for the modified amino acids are used. “U” denotes that an unspecified amino acid was
adducted. bAdduct-speciﬁc characteristics are those described in Figure 3. Spectral characteristics apply only to posi-
tive-ion tandem MS done by low-energy collision-induced dissociation on ion-trap and triple-quadrupole instruments.
cThe adduct was reduced with sodium borohydride before analysis.These unanticipated modifications would
yield adducted peptides that would not be
identified by directly searching the data for
peptides of the expected mass modiﬁcation.
The advantage of SALSA in these situations is
that it can identify MS–MS spectra for vari-
ant and modified peptides even when the
exact nature of the modification is not
known. This is because SALSA searching for
spectra with ion series motifs will detect ion
series patterns, which are at least partially con-
served in spectra of modiﬁed peptide forms.
Application of this approach to mapping
chemical adducts on proteins is ongoing in
our laboratory.
For analysis of modiﬁcations in complex
proteomes, Sequest and SALSA will likely be
used together to identify proteins in a sample
and to map the sites of modifications. The
general approach is illustrated in Figure 5. An
initial analysis of the data with Sequest would
successfully correlate many of the MS–MS
spectra with database sequences. Even if some
of the MS–MS spectra were of modiﬁed pep-
tides and thus were not correctly identiﬁed by
Sequest, other unmodified peptides from
those same proteins would be identiﬁed. This
initial Sequest search thus generates a list of
proteins represented in the sample. Next,
SALSA searches are done for the sequence
motifs represented by peptides from those
proteins. These sequence motif searches iden-
tify not only the MS–MS spectra of the
unmodified peptides but also the MS–MS
scans that have ion series homology to the
unmodified peptide spectra. These spectra
correspond to the modified peptides.
Inspection of these spectra will then allow
deduction of the mass and sequence location
of each modiﬁcation.
It is important to emphasize that this
approach is entirely dependent on the analyst’s
ability to obtain MS–MS spectra of the modi-
fied forms of peptides. This is not a trivial
point, because modiﬁed forms may often rep-
resent a small fraction of any particular pro-
tein. The analytical challenge then becomes
obtaining MS–MS spectra of the adducted
peptides in the presence of larger amounts of
unmodified peptides. Adduct detection
becomes even more difﬁcult when the target
protein(s) is of low abundance in mixtures
containing higher abundance proteins. This is
a particularly relevant issue when one consid-
ers that protein abundances may vary over
about six orders of magnitude. Despite these
challenges, the application of multidimen-
sional chromatographic separations prior to or
parallel with MS–MS analyses has proven
highly effective for analysis of complex pro-
teomes (10,45). Elaboration of similar
approaches will help maximize the opportu-
nity to record MS–MS spectra of lower abun-
dance peptide adducts in complex mixtures.
Protein Adducts as
Biomarkers of Exposure to
Environmental Chemicals
As MS and related proteomics approaches
continue to evolve, more investigators will be
able to identify protein adducts arising from
exposure to environmental chemicals. Protein
adducts may serve as markers of exposure to
environmental agents. This idea is certainly
not new, and a great deal of work has gone
into developing methods and applications of
hemoglobin and albumin adducts as markers
of exposure to reactive chemicals [for reviews,
see (46–48)]. Previous work on protein bio-
markers has involved identifying specific,
known chemical adducts on known protein
targets and then developing sensitive, speciﬁc
assays to detect those particular adducts.
Adaptation of proteomic approaches
could lead to the discovery of new adduct
biomarkers. For example, using LC–MS–MS
coupled with sequence motif searching with
the SALSA algorithm can identify multiple
adduct variants of a target peptide based on
ion series homology between the MS–MS
spectra of the unadducted and different
adducted peptides. We have recently demon-
strated that this approach can detect multiple
adducts of human hemoglobin exposed to
mixtures of aliphatic epoxides in vitro (49).
Once adducts are identified by proteomic
approaches, LC–MS–MS or immunoassays
may be developed to achieve quantification
in samples from study populations.
Protein Adducts as Triggers
for Stress Responses
Adduction of proteins may trigger deleterious
effects in living systems. This is a long-stand-
ing hypothesis that has nevertheless gone
largely unexplored because of limitations in
analytical technology. New techniques that
identify protein targets and that map protein
modiﬁcations will undoubtedly reinvigorate
this field. This will permit investigators to
investigate several hypotheses regarding the
mechanism(s) by which covalent modifica-
tions impact cellular functions. Certainly the
dominant hypothesis over the years is that
adduction results in an inhibition or loss of
function of the adducted proteins (12,20,50).
However, recent work suggests that oxidative
or alkylation modiﬁcations to proteins trigger
signaling cascades that result in activation of
stress genes and phenotypic changes. Work by
the Tew and Ronai groups indicates that glu-
tathione S-transferase P1-1 (GSTP1-1) serves
as a negative regulator of jun–N-terminal
kinase 1 (JNK1) through complexation that
sequesters JNK1 in an inactive form (51–54).
Prooxidant stress or ultraviolet irradiation
leads to dissociation of GSTP1-1 from JNK1
and to JNK1 activation (54). Similar studies
indicate that the redox proteins thioredoxin
(55) and glutathione S-transferase M1–1 (56)
serve as negative regulators of apoptosis sig-
nal-regulating kinase 1 (ASK1) through a
similar mechanism, in which prooxidant
stress results in thioredoxin or glutathione S-
transferase dissociation and ASK1 activation.
Similarly, work by Yamamoto and colleagues
revealed that the protein keap1 serves as a
redox- and alkylation-sensitive switch for acti-
vation of the transcription factor NRF2,
which is a principal activator of the elec-
trophile response element. Modification of
keap1 causes dissociation from NRF2, thus
permitting NRF2 entry into the nucleus,
complexation with other proteins, and activa-
tion of the electrophile response element
(57). Studies by Stevens and colleagues have
documented the ability of the prototypical
alkylating agent iodoacetamide to induce
the synthesis of endoplasmic reticulum
(ER)–associated stress proteins, including
Grp78, Grp94, and calreticulin, and the cyto-
plasmic stress protein Hsp70 (58–60). Other
studies have provided evidence that ER pro-
teins are prominent targets for reactive elec-
trophiles produced from P450 enzymes,
although no adducts have been mapped to
speciﬁc proteins (20). The ER stress response
involves activation of a complex signaling
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Figure 5. Integrated application of LC–MS–MS, Sequest, and SALSA to identify and map protein adducts.
See text for discussion.
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SALSAsystem with “sensory” components in the ER
that respond to unfolded or reduced proteins
and transduce signals that result in the activa-
tion of stress gene transcriptional regulators
(61). Although the mechanics of the signaling
mechanisms have been elucidated in yeast and
appear to be similar in higher eukaryotes, the
fundamental mechanisms by which ER pro-
tein modifications trigger the cascade are
obscure. This situation typiﬁes current under-
standing of other stress responses. Many of
the intermediate signaling events are becom-
ing clear, but the chemical/molecular initiat-
ing events remain unexplained except in the
most general terms (e.g., “protein damages”
“protein oxidation,” etc.). Application of ana-
lytical proteomics approaches offers new
opportunities to explicitly examine the roles
of speciﬁc protein adducts as triggers for gene
expression changes associated with stress.
Conclusion
The revolution in biology spawned by com-
pletion of genome sequences for humans
and other organisms offers tremendous
opportunities to explore mechanisms by
which environmental agents affect living sys-
tems. Proteomics approaches and gene
expression technologies will fuel the emerg-
ing discipline of toxicogenomics, which
describes the deleterious effects of chemicals
on the expression of genes and the functions
of gene products. Analytical proteomics
approaches employing MS instrumentation
and new data analysis tools will enable us to
study the interactions of reactive chemicals
with cellular proteins and proteomes. A pro-
teomics focus is particularly relevant to stud-
ies of environmental agents, because proteins
are often the initial point of contact with an
organism. Moreover, effects of chemicals on
proteins trigger diverse responses that con-
tribute to injury and disease. Proteomics
approaches will soon describe these mecha-
nisms and provide a new basis for under-
standing cell–environment interactions.
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